Raphael Campeas, MD
- 3Articles
- 11.2KReads1
- 1997–2015Active
- 27Collaborators
- 58Citations2
About
Raphael Campeas, MD, has published research on treatment approaches for obsessive-compulsive disorder and panic disorder. His work includes clinical trials evaluating augmentation strategies of serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with OCD. He has also studied the use of clomipramine in panic disorder. Campeas has collaborated with co-authors such as Michael R. Liebowitz and Edna B. Foa.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
